GE HealthCare Technologies Inc.

GEHC Healthcare Medical Devices

GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024. In the quarter to June 2026, revenue grew 5.75%, EPS grew 17.0%, free cash flow grew 750.0% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; dividend growth for three consecutive years, revenue growth for five; insiders bought in the last twelve months.

69.57 0.78 −1.11%
Market cap
$31.8B
P/E
16.0×
Fwd P/E
14.4×
Dividend yield
0.26%
F-score
4/9
Altman Z
1.96
Beneish M
−2.33
Dividend safety
74/100

GE HealthCare Technologies Inc. (GEHC) EV/FCF

Alert me on EV/FCF

As of 16 October 2026, GE HealthCare Technologies Inc. (GEHC) trades at a EV/FCF of 25.9×. Over the past ten years it has ranged from 17.6× (January 2023) to 35.4× (December 2022); the current reading is higher than 41% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 29.6× 6.42%
FY2024 27.8× 10.43%
FY2023 25.2× 42.89%
FY2022 17.6× (50.24%)
FY2021 35.4× 0.00%
FY2020 35.4× 0.00%
FY2019 35.4× —

Quarterly newest first

Period EV/FCF Change
Jun 2026 24.3× (11.41%)
Mar 2026 27.5× (7.22%)
Dec 2025 29.6× (1.41%)
Sep 2025 30.0× 12.92%
14 more quarters

Against its own ten years

Low 17.6× High 35.4×
Ten-year median 26.6×
Current reading's percentile 41

EV/FCF against peers

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on GEHC